Intrinsic Value of S&P & Nasdaq Contact Us

MeiraGTx Holdings plc MGTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+59.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MeiraGTx Holdings plc (MGTX) has a negative trailing P/E of -6.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 13.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -14.95%, forward earnings yield 7.20%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+59.4%).
  • Forward P/E 13.9 — analysts expect a return to profitability with estimated EPS of $0.81 for FY2030.
  • Trailing Earnings Yield -14.95% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 7.20% as earnings recover.
  • Analyst consensus target $18.00 (+59.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
56/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MGTX

Valuation Multiples
P/E (TTM)-6.7
Forward P/E13.9
PEG RatioN/A
Forward PEGN/A
P/B Ratio-131.91
P/S Ratio9.43
EV/EBITDA-9.4
Per Share Data
EPS (TTM)$-1.41
Forward EPS (Est.)$0.81
Book Value / Share$-0.07
Revenue / Share$1.00
FCF / Share$-0.70
Yields & Fair Value
Earnings Yield-14.95%
Forward Earnings Yield7.20%
Dividend Yield0.00%
Analyst Target$18.00 (+59.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -14.8 0.00 -16.84 0.00 -
2017 -4.1 -0.02 -2.71 0.00 -
2018 -2.2 -0.11 2.25 0.00 -
2019 -12.1 0.19 3.48 49.95 -
2020 -9.8 1.04 2.39 36.70 -
2021 -13.2 -0.94 5.65 27.79 -
2022 -2.3 -0.02 2.50 18.50 -
2023 -4.7 0.09 2.87 28.29 -
2024 -2.9 -0.07 6.27 12.78 -
2025 -5.6 0.17 -110.38 7.86 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.01 $0.00 $-19.49M -
2017 $-3.62 $0.00 $-31.04M -
2018 $-4.37 $0.00 $-82.87M -
2019 $-1.58 $13.29M $-52.56M -395.4%
2020 $-1.43 $15.56M $-53.96M -346.7%
2021 $-1.63 $37.7M $-71.98M -190.9%
2022 $-3.16 $15.92M $-142.88M -897.5%
2023 $-1.49 $14.02M $-84.03M -599.5%
2024 $-2.12 $33.28M $-147.79M -444.1%
2025 $-1.42 $81.39M $-114.2M -140.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.36 $-3.61 – $1.18 $746K $32.85K – $1.41M 5
2027 $-1.03 $-2.11 – $1.12 $36.6M $15.92M – $57.26M 3
2028 $-1.64 $-2.60 – $-1.05 $101.22M $100.44M – $102M 3
2029 $-0.33 $-0.67 – $0.03 $216.16M $33.8M – $387.97M 1
2030 $0.81 $-0.08 – $1.65 $374.77M $58.6M – $672.63M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message